Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia

Background: Patients with elevated levels of serum triglyc‐erides (TG) often have other associated lipid abnormalities (e.g., low levels of high‐density lipoprotein cholesterol [HDL‐C]) and are at increased risk of developing coronary heart disease. Although the therapeutic benefits of 3‐hydroxy‐3‐m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cardiol
Autori principali: Isaacsohn, Jonathan, Hunninghake, Donald, Schrott, Helmut, Dujovne, Carlos A., Knopp, Robert, Weiss, Stuart R., Bays, Harold, Crousei, John R., Davidson, Michael H., Keilson, Leonardm, McKenney, James, Korenman, Stanleyg, Dobs, Adrians, Stein, Evan, Krauss, Ronald M., MacCubbin, Darbie, Cho, Meeh Yung, Plotkin, Diane J., Mitchel, YALE B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley Periodicals, Inc. 2006
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654219/
https://ncbi.nlm.nih.gov/pubmed/12539808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960260105
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi